Literature DB >> 8976317

Pathological crying and laughing: treatment with sertraline.

J Mukand1, M Kaplan, R G Senno, D S Bishop.   

Abstract

OBJECTIVE: To evaluate the efficacy of sertraline for treating pathological laughing and crying after stroke.
DESIGN: Case series.
SETTING: Inpatient rehabilitation units of a community and a tertiary-care hospital. PATIENTS: One patient was a 62-year-old right-handed man who had two strokes approximately 2 years apart and had computed tomography consistent with a cerebral infarct involving the left middle cerebral artery branches in the left parietal lobe. A second patient was a 72-year-old right-handed man who had a right middle cerebral artery infarct. He had a questionable history of depression prior to the stroke. INTERVENTION: Both patients had poststroke labile affect that was interfering with their rehabilitation. Sertraline was prescribed. MAIN OUTCOME MEASURES: Pretreatment and posttreatment scores on the Pathological Crying and Laughing Scale and Functional Independent Measure.
RESULTS: Both patients showed significant improvement after taking sertraline-improvement that was reflected in their pretreatment and posttreatment scores on the Pathological Crying and Laughing Scale and Functional Independent Measure. The staff noted improvements in sleeping, eating, social interaction, and therapy participation. Both patients tolerated the sertraline well and had no significant side effects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8976317     DOI: 10.1016/s0003-9993(96)90198-7

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  8 in total

Review 1.  Pathological laughing and crying : epidemiology, pathophysiology and treatment.

Authors:  Hal S Wortzel; Timothy J Oster; C Alan Anderson; David B Arciniegas
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 2.  Current concepts in the pharmacotherapy of pseudobulbar affect.

Authors:  Erik P Pioro
Journal:  Drugs       Date:  2011-06-18       Impact factor: 9.546

3.  [Amyotrophic lateral sclerosis: management of bulbar symptoms].

Authors:  P Kraft; M Beck; A Grimm; C Wessig; K Reiners; K V Toyka
Journal:  Nervenarzt       Date:  2010-10       Impact factor: 1.214

4.  Pharmaceutical interventions for emotionalism after stroke.

Authors:  Sabine Allida; Kulsum Patel; Allan House; Maree L Hackett
Journal:  Cochrane Database Syst Rev       Date:  2019-03-19

5.  Effective use of sertraline for pathological laughing after severe vasospasm due to aneurysmal subarachnoid hemorrhage: case report.

Authors:  Hayato Takeuchi; Kazuhide Iwamoto; Mao Mukai; Tomoaki Fujita; Hitoshi Tsujino; Yoshihiro Iwamoto
Journal:  Neurol Med Chir (Tokyo)       Date:  2013-11-08       Impact factor: 1.742

Review 6.  Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect.

Authors:  Kerri A Schoedel; Sarah A Morrow; Edward M Sellers
Journal:  Neuropsychiatr Dis Treat       Date:  2014-06-26       Impact factor: 2.570

7.  Altered serotonin, dopamine and norepinepherine levels in 15q duplication and Angelman syndrome mouse models.

Authors:  M Febin Farook; Michael DeCuypere; Keith Hyland; Toru Takumi; Mark S LeDoux; Lawrence T Reiter
Journal:  PLoS One       Date:  2012-08-16       Impact factor: 3.240

8.  Correlation between cognitive impairment during the acute phase of first cerebral infarction and development of long-term pseudobulbar affect.

Authors:  Yuan Wang; Yuliang Wang; Wenbin Ma; Shujun Lu; Jinbo Chen; Lili Cao
Journal:  Neuropsychiatr Dis Treat       Date:  2018-03-28       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.